Skip to main content

Table 5 Comparison of biochemical parameters from baseline to third follow-up

From: Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: a prospective evaluation

Variables (Units)Baseline N = 29First follow-up N = 29Second follow-up N = 29Third follow-up N = 29P value
SGOT (U/L)
 Median (IQR)41.00 (6.00)38.00 (5.50)40.00 (5.50)41.00 (5.00) 
 Mean ± SD41.00 ± 4.2939.17 ± 6.5040.76 ± 5.7742.14 ± 5.660.10
SGPT (U/L)
 Median (IQR)40.00 (4.00)40.00 (4.00)41.00 (6.50)39.00 
 Mean ± SD39.90 ± 3.5840.52 ± 5.2141.28 ± 5.96(11.00) 41.62 ± 7.820.99
ALP (U/L)
 Median (IQR)78.00 (12.00)78.00 (6.50)78.00 (6.50)72.00 
 Mean ± SD77.69 ± 8.0479.83 ± 7.7978.72 ± 6.02(11.00) 73.62 ± 5.700.64
Bilirubin (mg/dL)
 Median (IQR)1.00 (0.35)0.90 (0.45).90 (0.35)1.00 (0.40)0.016
 Mean ± SD1.06 ± 0.230.89 ± 0.260.92 ± 0.321.01 ± 0.29
Urea (mg/dL)
 Median (IQR)36.00 (7.00)35.00 (8.50)40.00 (6.50)38.00 (5.50) 
 Mean ± SD37.38 ± 3.9538.48 ± 6.6839.66 ± 6.6138.44 ± 5.420.82
Creatinine (ng/mL)
 Median (IQR)0.80 (0.40)1.00 (0.55)0.80 (0.40)0.80 (0.35)0.98
 Mean ± SD0.86 ± 0.300.94 ± 0.350.88 ± 0.360.91 ± 0.30
Random blood sugar (mg/dL)
 Median (IQR)80.00 (11.50)88.0089.00 (6.00)89.000.031
 Mean ± SD85.76 ± 17.16(10.00) 92.79 ± 18.4093.00 ± 15.04(10.00) 92.28 ± 18.50
  1. ALP Alkaline phosphatase, IQR Inter-quartile range, SD standard deviation, SGOT serum glutamic-oxalacetic transaminase, SGPT serum glutamic-pyruvic transaminase
  2. Note: Statistically significant P values have been italicized